Cargando…
Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer
The aim of the study was to examine the effectiveness of fluorine-18 fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) versus bone scintigraphy (BS) in treatment response assessment of bone metastases in breast cancer. The medical records of breast cancer pat...
Autores principales: | Al-Muqbel, Kusai M., Yaghan, Rami J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902366/ https://www.ncbi.nlm.nih.gov/pubmed/27227942 http://dx.doi.org/10.1097/MD.0000000000003753 |
Ejemplares similares
-
Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis
por: Park, Soyeon, et al.
Publicado: (2017) -
Bone Marrow Metastasis Is an Early Stage of Bone Metastasis in Breast Cancer Detected Clinically by F18-FDG-PET/CT Imaging
por: Al-Muqbel, Kusai M.
Publicado: (2017) -
Volume-based metabolic parameter of breast cancer on preoperative (18)F-FDG PET/CT could predict axillary lymph node metastasis
por: An, Young-Sil, et al.
Publicado: (2017) -
CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer
por: Jung, Ji-hoon, et al.
Publicado: (2017) -
Synovial sarcoma with isolated bone metastases, demonstrated by (99m)Tc-MDP bone scintigraphy and (18)F-FDG PET/CT
por: Senthil, Raja, et al.
Publicado: (2012)